SST and medulloblastoma: As regards the utilization of theragnostic radiopharmaceuticals in children with brain tumors, pediatric patients with recurrent medulloblastoma, one of the most aggressive childhood tumors, may benefit from somatostatin receptor imaging to allow a possible radionuclide therapy with radiolabeled somatostatin analogs.